Skip to application
All calculators and tools

Preparation. Administration. Evidence.

IV Dilution &
Medication Reference

Search 255 medications, read preserved historical references, and inspect separately reviewed preparation statements. Full monograph updates remain pending.

Version 6.4Release date 2026-11-04For healthcare professionals
Back to resultsA-Z list

Medication reference

Remdesivir

Limited reviewed summaryThis monograph will be updated in the future.

Jump to a section
Selected DailyMed label (opens in a new tab)

No original site article was mapped to this record. The available historical structured fields and official-source links are retained.

Historical first look: uses, mechanism, dosing context, and administration

Recovered v5.1 source content; historical, awaiting current review.

Id
remdesivir
Source IDH51-3EE03E2FABDE8EAAC50447F4
Generic name
Remdesivir
Source IDH51-3E312B5598C3385E142248F4
Class
Antiviral
Source IDH51-BBD597507845519771CAC329
Subclass
Nucleotide analog
Source IDH51-9C6AB8179EC96AD09121265F
Primary uses
  1. COVID-19 in eligible adult and pediatric patients
    Source IDH51-0EDFBE7EB482E6023783C673
Mechanism
Its active nucleotide triphosphate competes for viral RNA polymerase incorporation and disrupts RNA synthesis.
Source IDH51-F8F5F687D61EFF0AD2B3CFB4
Mechanism level
drug_specific
Source IDH51-12C98E8B94DB1A226DE2A762
Basic dosing orientation
Adult | Existing preparation record; use current package insert for indication-specific selection | 200 mg loading then 100 mg daily in common regimen | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion; Pediatric | Existing preparation record; use current package insert for indication-specific selection | Weight-based loading and maintenance when under 40 kg | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion
Source IDH51-830375731F7D6B4F5754AA84
Administration orientation
Infuse over 30 to 120 minutes
Source IDH51-C7D4E675B99BDDD0B10E5DCB
Renal and population orientation
Separate renal reference: Open Renal Dosing Master (opens in a new tab)Renal function materially affects toxicity, monitoring, or titration even when a fixed table may not apply.
Source IDH51-C939BB9FAEC15DFD8ABCDDC4
Key safety orientation
  1. Infusion-related and hypersensitivity reactions.
    Source IDH51-438E846DC7F161946F6EFC40
  2. Monitor hepatic tests; formulation excipient considerations apply in renal dysfunction but current labeling should control.
    Source IDH51-9365742A7BAC36D93B2CD4CF
Coverage path
structured_local_snapshot
Source IDH51-366C0898A21D25D91BE93E2A
Coverage path label
Structured GlobalRPh route snapshot
Source IDH51-F65606D938EA15AA40C456C4
Review note
First-look orientation only. Verify indication, patient population, weight basis, organ function, exact IV product, dose, concentration, compatibility, rate, and current labeling before use.
Source IDH51-B02E072D7EBB7C03B83087D6
Search text
Remdesivir Antiviral Nucleotide analog COVID-19 in eligible adult and pediatric patients Its active nucleotide triphosphate competes for viral RNA polymerase incorporation and disrupts RNA synthesis. Adult | Existing preparation record; use current package insert for indication-specific selection | 200 mg loading then 100 mg daily in common regimen | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion; Pediatric | Existing preparation record; use current package insert for indication-specific selection | Weight-based loading and maintenance when under 40 kg | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion Infuse over 30 to 120 minutes Renal function materially affects toxicity, monitoring, or titration even when a fixed table may not apply. Infusion-related and hypersensitivity reactions. Monitor hepatic tests; formulation excipient considerations apply in renal dysfunction but current labeling should control. Structured GlobalRPh route snapshot VEKLURY VEKLURY (remdesivir) injection and powder for injection DailyMed label snapshot dosage administration dosage forms strengths mechanism
Source IDH51-5E6D7D91B264175F571D50C2
Official access mode
direct_label
Source IDH51-95B25C3195C486DF44AE3F60
Official search query
Remdesivir
Source IDH51-1B030878C3AAF9E7640429B5
Official access reason
Very-high-confidence exact IV product label selected during the v5.1 build-time review. Open the current full DailyMed monograph and verify the stocked product before use.
Source IDH51-FC1D49AB09B91E59159293A8
Label snapshot available
true
Source IDH51-103B2104E953C771FEB2D3C4
Label snapshot setid
c0978fa8-53ff-4ca2-82a7-567fd3e958ca
Source IDH51-B847D79AF26FA203217D49D2

Reviewed statements and exact sources

These statements have a limited product-specific scope. Full dosing, compatibility, renal, dialysis and monitoring review remains pending.

Reconstitution

For the 100 mg lyophilized vial, add 19 mL Sterile Water for Injection.

Claim ID: IVR-REMDESIVIR-001

Applies to: VEKLURY 100 mg lyophilized single-dose vial, Gilead; adult preparation only. Excludes the liquid presentation retained in older SPL product data.

Source 1, source 2, and exact locations

Review basis: Separately authored institutional guidance

  1. Source 1

    VEKLURY (remdesivir) injection and powder for injection (opens in a new tab)

    Exact location: 2.5 Preparation and Administration; Reconstitution Instructions; section UUID b075f3e0-cbcf-4cdf-876b-edf10a13adaa

    Publisher: National Library of Medicine / DailyMed; labeler-submitted U.S. SPL

    Source family: U.S. product prescribing information

    Retrieved: 2026-11-04T18:47:24.060516+00:00

    A retrieved label is one evidence source. Downloading an XML file does not establish an independently corroborated clinical monograph or current availability of every listed presentation.

  2. Source 2

    Remdesivir intravenous infusion for adults (opens in a new tab)

    Exact location: Reconstitution; first instruction for the Veklury 100 mg vial

    Publisher: Galway University Hospitals / Medinfo Galway

    Source family: Independent institutional administration guide (Ireland)

    Retrieved: 2026-11-04T18:56:57.610191+00:00

    Separately authored institutional guidance, partly based on product labeling. Used only for explicitly concordant preparation statements; Irish policy and formulation-specific differences are not transferred to U.S. products. Not independent primary trial evidence.

Reconstitution

The resulting reconstituted solution contains 5 mg/mL (100 mg in 20 mL).

Claim ID: IVR-REMDESIVIR-002

Applies to: VEKLURY 100 mg lyophilized single-dose vial, Gilead; adult preparation only. Excludes the liquid presentation retained in older SPL product data.

Source 1, source 2, and exact locations

Review basis: Separately authored institutional guidance

  1. Source 1

    VEKLURY (remdesivir) injection and powder for injection (opens in a new tab)

    Exact location: 2.5; Reconstitution Instructions; final concentration paragraph; section UUID b075f3e0-cbcf-4cdf-876b-edf10a13adaa

    Publisher: National Library of Medicine / DailyMed; labeler-submitted U.S. SPL

    Source family: U.S. product prescribing information

    Retrieved: 2026-11-04T18:47:24.060516+00:00

    A retrieved label is one evidence source. Downloading an XML file does not establish an independently corroborated clinical monograph or current availability of every listed presentation.

  2. Source 2

    Remdesivir intravenous infusion for adults (opens in a new tab)

    Exact location: Reconstitution; stated final concentration

    Publisher: Galway University Hospitals / Medinfo Galway

    Source family: Independent institutional administration guide (Ireland)

    Retrieved: 2026-11-04T18:56:57.610191+00:00

    Separately authored institutional guidance, partly based on product labeling. Used only for explicitly concordant preparation statements; Irish policy and formulation-specific differences are not transferred to U.S. products. Not independent primary trial evidence.

Dilution

Further dilute the reconstituted drug with 0.9% Sodium Chloride Injection before infusion.

Claim ID: IVR-REMDESIVIR-003

Applies to: VEKLURY 100 mg lyophilized single-dose vial, Gilead; adult preparation only. Excludes the liquid presentation retained in older SPL product data.

Source 1, source 2, and exact locations

Review basis: Separately authored institutional guidance

  1. Source 1

    VEKLURY (remdesivir) injection and powder for injection (opens in a new tab)

    Exact location: 2.1 Dosage and Administration Overview; final bullet; 2.5 Dilution Instructions

    Publisher: National Library of Medicine / DailyMed; labeler-submitted U.S. SPL

    Source family: U.S. product prescribing information

    Retrieved: 2026-11-04T18:47:24.060516+00:00

    A retrieved label is one evidence source. Downloading an XML file does not establish an independently corroborated clinical monograph or current availability of every listed presentation.

  2. Source 2

    Remdesivir intravenous infusion for adults (opens in a new tab)

    Exact location: Infusion fluids; and Reconstitution, further-dilution instruction

    Publisher: Galway University Hospitals / Medinfo Galway

    Source family: Independent institutional administration guide (Ireland)

    Retrieved: 2026-11-04T18:56:57.610191+00:00

    Separately authored institutional guidance, partly based on product labeling. Used only for explicitly concordant preparation statements; Irish policy and formulation-specific differences are not transferred to U.S. products. Not independent primary trial evidence.

Infusion

For the reviewed adult preparation, administer the diluted dose by IV infusion over 30 to 120 minutes.

Claim ID: IVR-REMDESIVIR-004

Applies to: VEKLURY 100 mg lyophilized single-dose vial, Gilead; adult preparation only. Excludes the liquid presentation retained in older SPL product data.

Source 1, source 2, and exact locations

Review basis: Separately authored institutional guidance

  1. Source 1

    VEKLURY (remdesivir) injection and powder for injection (opens in a new tab)

    Exact location: 2.5 Administration Instructions for Adults and Pediatric Patients Weighing at Least 40 kg; section UUID bb45afbc-26f0-405f-8d53-ea1baf8f27ab

    Publisher: National Library of Medicine / DailyMed; labeler-submitted U.S. SPL

    Source family: U.S. product prescribing information

    Retrieved: 2026-11-04T18:47:24.060516+00:00

    A retrieved label is one evidence source. Downloading an XML file does not establish an independently corroborated clinical monograph or current availability of every listed presentation.

  2. Source 2

    Remdesivir intravenous infusion for adults (opens in a new tab)

    Exact location: Methods of intravenous administration; infusion-time instruction and table

    Publisher: Galway University Hospitals / Medinfo Galway

    Source family: Independent institutional administration guide (Ireland)

    Retrieved: 2026-11-04T18:56:57.610191+00:00

    Separately authored institutional guidance, partly based on product labeling. Used only for explicitly concordant preparation statements; Irish policy and formulation-specific differences are not transferred to U.S. products. Not independent primary trial evidence.

Product identifiers and clinical review status

This monograph will be updated in the future. The individually cited reviewed claims below have completed a limited review; restored historical material remains separately labelled and unverified.

Primary label metadata - product reconciliation incomplete

Matched U.S. label formulation for the limited claims; full monograph identity review remains incomplete.

View product identifiers and primary-label provenance
Selected product scope
VEKLURY 100 mg lyophilized single-dose vial, Gilead; adult preparation only. Excludes the liquid presentation retained in older SPL product data.
Field ID: IVR-REMDESIVIR-META-PRODUCT-SCOPE

Primary source (opens in a new tab) | Product data elements and the claim-specific formulation described in the cited preparation sections

Complete product reconciliation: pending.

Labeler
Gilead Sciences, Inc.
Field ID: IVR-REMDESIVIR-META-LABELER

Primary source (opens in a new tab) | SPL author/assignedEntity/representedOrganization/name

Complete product reconciliation: pending.

Application number(s)
NDA214787
Field ID: IVR-REMDESIVIR-META-APPLICATION-NUMBERS

Primary source (opens in a new tab) | SPL subjectOf/approval/id/@extension

Complete product reconciliation: pending.

NDC(s)
61958-2901-2
Field ID: IVR-REMDESIVIR-META-NDCS

Primary source (opens in a new tab) | SPL manufacturedProduct/asContent/containerPackagedProduct/code/@code and How Supplied

Complete product reconciliation: pending.

DailyMed Set ID
c0978fa8-53ff-4ca2-82a7-567fd3e958ca
Field ID: IVR-REMDESIVIR-META-SETID

Primary source (opens in a new tab) | SPL document/setId/@root

Complete product reconciliation: pending.

SPL version
24
Field ID: IVR-REMDESIVIR-META-SPL-VERSION

Primary source (opens in a new tab) | SPL document/versionNumber/@value

Complete product reconciliation: pending.

Label printed revision date
Not independently reconciled
Field ID: IVR-REMDESIVIR-META-LABEL-REVISION-DATE

Primary source (opens in a new tab) | Printed revision statement in the selected label; distinct from SPL effectiveTime

Complete product reconciliation: pending.

SPL effective date
2026-07-29
Field ID: IVR-REMDESIVIR-META-REVISION-DATE

Primary source (opens in a new tab) | SPL document/effectiveTime/@value

Complete product reconciliation: pending.

Retrieved
2026-11-04T18:47:24.060516+00:00
Field ID: IVR-REMDESIVIR-META-RETRIEVED-AT

Primary source (opens in a new tab) | Timestamp recorded when source bytes were retrieved

Complete product reconciliation: pending.

Downloaded XML SHA-256
1200ee513a4816f5ab4dc0cefea66a7a67f3a6e012cc9fe56175ce80f7d70bb6
Field ID: IVR-REMDESIVIR-META-XML-SHA256

Primary source (opens in a new tab) | SHA-256 computed over the exact downloaded XML bytes

Complete product reconciliation: pending.

What remains to be completed
  • A complete indication-specific adult, pediatric and neonatal dosing review
  • Complete product reconciliation across formulation, container, manufacturer/labeler, application and NDC
  • Renal-function method, population and dose-adjustment reconciliation
  • Modality-specific intermittent dialysis and CRRT parameters and dosing
  • Comprehensive incompatibility, stability, sterility-based BUD and monitoring review

Supplemental historical fields

Restored-data provenance and review notes

Source release: 2026-08-31. Current clinical review is incomplete. Original uses of current, verified, or normalized describe the historical source. They do not inherit the status of separately reviewed statements. Product formulations and source dates can differ.

Current review annotations for historical renal, dialysis, mechanism, and product fieldsSeparate renal reference: Open Renal Dosing Master (opens in a new tab)
Renal
Status
not_locally_normalized
Original classification
monitor_or_titrate
Entries
    General note
    Preserve the source-specific renal-function basis. An indexed CrCl table is not interchangeable with unindexed CrCl or eGFR. Generic advice to check a method does not identify the equation for a dose row.
    Dialysis
    Status
    no_local_structured_regimen
    Entries
      General note
      Named modality alone does not establish applicability. CRRT subtype, effluent rate, residual renal function, timing and interruptions require review. Historical absence is not evidence that no guidance exists.
      Mechanisms
      • Source kind
        first_look
        Local pointer
        /mechanism
        Original level
        drug_specific
        Provenance classification
        historical_drug_specific_uncorroborated
        Label derived verified
        false
        Independently corroborated
        false
        Exact label section
        Not recorded
        Original source note
        Not recorded
        Review status
        historical_unverified
        Note
        Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
      • Source kind
        label_snapshot
        Local pointer
        /mechanism_summary
        Original level
        drug_specific
        Provenance classification
        historical_drug_specific_uncorroborated
        Label derived verified
        false
        Independently corroborated
        false
        Exact label section
        Not recorded
        Original source note
        Concise GlobalRPh summary reviewed against the selected DailyMed label clinical-pharmacology or microbiology content.
        Review status
        historical_unverified
        Note
        Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
      Future update
      Status
      pending_review
      Message
      This monograph will be updated in the future as current exact-product and claim-level review is completed.
      Source unavailable
      false
      Reason
      The historical content is restored; comprehensive contemporary verification remains incomplete.

      No separate structured rows were bundled for IV push, continuous infusion, dialysis, CRRT. Historical article content and source links may cover these topics.

      Historical dilution and intermittent infusion preparation

      Recovered v5.1 source content; historical, awaiting current review.

      PopulationAmountReconstitutionDiluentFinal volumeConcentrationRateStabilityNotes
      Source IDH51-006760AF95E341F49941C539
      Adult
      Source IDH51-FB6367DAEE2ED009DB90FC0E
      		200 mg loading then 100 mg daily in common regimen
      Source IDH51-025FA0C6B08D9ACA8042626B
      		Reconstitute lyophilized vial with 19 mL Sterile Water for Injection; solution formulation does not require reconstitution.
      Source IDH51-D896B4F4E5EC38AAE880ACF3
      		NS only
      Source IDH51-7773C8BF47872E6A34028BF8
      		100 or 250 mL
      Source IDH51-00FD40E464F70435A06910B3
      		Final concentration depends on bag size
      Source IDH51-114BC91A2A561C46F8BA917F
      		Infuse over 30 to 120 minutes
      Source IDH51-F11604BEC3340BD59E7AC9C7
      		Use the shorter of current product labeling, validated stability data, and the applicable USP <797> sterility-based BUD ceiling.
      Source IDH51-F2B18F7D664FFC004841D1EE
      		Use the correct withdrawal volume for lyophilized versus solution formulations.
      Source IDH51-FD8A45F014052A716AEA83A9
      Source IDH51-D270098D0A77FEADA30522BF
      Pediatric
      Source IDH51-07380EF15B22776892D52BC8
      		Weight-based loading and maintenance when under 40 kg
      Source IDH51-26B1BB4FC1AE41F161CA3B4D
      		Use age/weight-appropriate formulation and label table.
      Source IDH51-1504AB3BCB21A4F8E2D08CEA
      		NS
      Source IDH51-CEF4A6CFBAD9E4FC64DC7B9C
      		Weight-appropriate volume
      Source IDH51-6F2385479E3162FCE9540F78
      		Label-specified
      Source IDH51-991E45C15691301CA73BBB0A
      		Infuse over 30 to 120 minutes
      Source IDH51-FF924E4B2446DC0218284CBD
      		Use the shorter of current product labeling, validated stability data, and the applicable USP <797> sterility-based BUD ceiling.
      Source IDH51-8EB5ABE7C6A1DBB4B1083FD6

      Historical DailyMed label snapshot

      Recovered v5.1 source content; historical, awaiting current review.

      Id
      remdesivir
      Source IDH51-B63BCC538C7D742C6B35AF22
      Catalog name
      Remdesivir
      Source IDH51-7F2F0EEE57FC0F25C89DB08F
      Selection status
      accepted_high_confidence
      Source IDH51-2B56366B509DFA926A8B0607
      Confidence
      very_high
      Source IDH51-83E5E086147C66E21F12CEEC
      Match path
      search_to_exact_label
      Source IDH51-B102E51F24D0DE9347356FDF
      Brand name
      VEKLURY
      Source IDH51-D0E8AC1FE8BA17B5DDE93889
      Label title
      VEKLURY (remdesivir) injection and powder for injection
      Source IDH51-776B1F5D33EE4DFC238957B9
      Setid
      c0978fa8-53ff-4ca2-82a7-567fd3e958ca
      Source IDH51-5FAE3D58CDE18F123BF3FF0B
      Route
      Intermittent intravenous infusion
      Source IDH51-1EE71CD83D4ECF79DEF15CFD
      Dosage form
      Lyophilized powder or solution for intravenous infusion
      Source IDH51-7602DE5580859B2A9039116C
      Dosage administration summary
      Separate renal reference: Open Renal Dosing Master (opens in a new tab)
      1. For adults and pediatric patients weighing at least 40 kg, administer 200 mg on day 1 followed by 100 mg once daily. Lower-weight pediatric patients use weight-based dosing.
        Source IDH51-23E51DC2E659CD42E2467CFE
      2. Administer only by intravenous infusion over 30 to 120 minutes after the formulation-specific preparation steps.
        Source IDH51-21A11E9A22FA55F90AEED13C
      3. Treatment duration depends on setting, disease severity, and clinical response; review current renal, hepatic, and testing recommendations before use.
        Source IDH51-1AA02A9FAA4BB28EAA03FD00
      Dosage forms strengths
      1. 100 mg lyophilized powder in a single-dose vial
        Source IDH51-0FA5C1D1291400414F5264C8
      2. 100 mg/20 mL solution in a single-dose vial
        Source IDH51-40BFE097EF260753D2C4FBCC
      Mechanism summary
      Remdesivir is converted intracellularly to a nucleotide triphosphate analog that inhibits SARS-CoV-2 RNA-dependent RNA polymerase.
      Source IDH51-FD0219CA05C347628B8A92F9
      Scope note
      Selected VEKLURY label. Preparation differs between the powder and solution presentations.
      Source IDH51-79F1AA3F7DDF42602EEDC3C3
      Reviewed on
      2026-08-31
      Source IDH51-C9F1CD31B23256380F793714
      Mechanism source
      Concise GlobalRPh summary reviewed against the selected DailyMed label clinical-pharmacology or microbiology content.
      Source IDH51-DE2A32BF60E6BE90448EC945
      Source sections
      1. Dosage and Administration
        Source IDH51-570673715AB10D8C140A037A
      2. Dosage Forms and Strengths
        Source IDH51-BA1FBEF4366D62E84EF11B2D
      3. Clinical Pharmacology or Microbiology as applicable
        Source IDH51-E6A98A478E669C4778F725C4
      Retrieval method
      Manual build-time review of the current DailyMed full prescribing information for the selected Set ID; no live server retrieval is required during page use.
      Source IDH51-2F41D8A35B901B5D197CF1DC
      Label status
      current
      Source IDH51-F5A9071EE22F7963F2B88194
      Disclaimer
      Verify the exact formulation, strength, manufacturer, NDC, route, current label revision, patient-specific order, institutional policy, and monitoring before use.
      Source IDH51-981D824C1C023D758FA9E2BB

      Historical indication and population dosing

      Recovered tables and source-separated snapshots; full clinical revalidation remains pending.

      Existing dose and route snapshots

      RoutePopulationIndicationDoseIntervalDurationAdministrationSource levelNotes
      Source IDH51-36FD0D1E7BE590211BF7AC70
      IV infusion
      Source IDH51-3B7EC60C5C105A1AC52FF215
      		Adult
      Source IDH51-DAEF11868CA9AE80D8CA37B2
      		Existing preparation record; use current package insert for indication-specific selection
      Source IDH51-310B3E9AF8272BBF65F0FD31
      		200 mg loading then 100 mg daily in common regimen
      Source IDH51-5470E45B351D8495C595BF4D
      		Not normalized in the preparation record
      Source IDH51-19A3CFE8A0E16C66E8B1D1B8
      		See current package insert and professional guidance
      Source IDH51-82F3787C9475044D088C63A2
      		Infuse over 30 to 120 minutes
      Source IDH51-C0BBD2BAC9D799061001A015
      		Existing GlobalRPh structured preparation snapshot
      Source IDH51-C751FE819F1C5FB32B5BF273
      		Use the correct withdrawal volume for lyophilized versus solution formulations.
      Source IDH51-EE050F98029868396D453E70
      Source IDH51-E832766D5797285A4C723388
      IV infusion
      Source IDH51-576A02604211DE59EC54AAD5
      		Pediatric
      Source IDH51-0D764B38E5D1DA951EFD871A
      		Existing preparation record; use current package insert for indication-specific selection
      Source IDH51-B600A570544AF1D3B2B462EB
      		Weight-based loading and maintenance when under 40 kg
      Source IDH51-BD0F6E0A0D57153517AB2BCD
      		Not normalized in the preparation record
      Source IDH51-1562D124974C8EA617D9E714
      		See current package insert and professional guidance
      Source IDH51-4826167DF91B0234B3DD4317
      		Infuse over 30 to 120 minutes
      Source IDH51-99720EB5F5F07A0BCF67392D
      		Existing GlobalRPh structured preparation snapshot
      Source IDH51-8082DC1039031B5C64739C07

      Historical renal-function guidance

      Recovered v5.1 source content; historical, awaiting current review.

      Separate renal reference: Open Renal Dosing Master (opens in a new tab)
      Classification
      monitor_or_titrate
      Source IDH51-3892ACECA10D0284AEB78FF3
      Summary
      Renal function materially affects toxicity, monitoring, or titration even when a fixed table may not apply.
      Source IDH51-9E097E79A3DDD1729AC48341
      Method note
      Use the renal function estimate and body-size convention specified by the selected label or institutional protocol. Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source.
      Source IDH51-1E529D18C029935DADB40C02

      Historical Common IV uses

      Recovered v5.1 source content; historical, awaiting current review.

      1. COVID-19 in eligible adult and pediatric patients
        Source IDH51-8DF646AEB7A4C13C9A44F0F6

      Historical Warnings and safeguards

      Recovered v5.1 source content; historical, awaiting current review.

      Separate renal reference: Open Renal Dosing Master (opens in a new tab)
      1. Infusion-related and hypersensitivity reactions.
        Source IDH51-18240A8704174CE20144D2D9
      2. Monitor hepatic tests; formulation excipient considerations apply in renal dysfunction but current labeling should control.
        Source IDH51-21CB65A0AE81EDB37131ED4A

      Historical Monitoring

      Recovered v5.1 source content; historical, awaiting current review.

      Separate renal reference: Open Renal Dosing Master (opens in a new tab)
      1. Hepatic tests before and during therapy
        Source IDH51-454F0F1DC77CFFE0D241D1E0
      2. Infusion reaction
        Source IDH51-27C1365195BA1CE8888E644A
      3. Renal function and clinical response
        Source IDH51-78741D3BD79D117B69743EAF

      Historical supplemental professional sources

      Recovered v5.1 source content; historical, awaiting current review.

      LabelUrlKind
      Source IDH51-49BE17625649164F03E220FB
      UCSF adult antimicrobial dosing, non-dialysis
      Source IDH51-85F68C86913E3F6CE8332A44
      		https://idmp.ucsf.edu/adult-antimicrobial-dosing-non-dialysis (opens in a new tab)
      Source IDH51-7E5115C63CB69EC266818915
      		Professional institutional guidance
      Source IDH51-4A91461B7EA1AD6C9E7D28C0
      Source IDH51-BDC779174F72CECB3FDE07DB
      UCSF antimicrobial dosing in intermittent and continuous hemodialysis
      Source IDH51-F985C229517291699A01D3E7
      		https://idmp.ucsf.edu/antimicrobial-dosing-intermittent-continuous-hemodialysis (opens in a new tab)
      Source IDH51-4EABAEF4FDC0BAB4358F192F
      		Professional institutional guidance
      Source IDH51-9FCA4EAD75AA4347C599EC60
      Source IDH51-AC92F6697ACA70461CA29756
      UCSF pediatric antimicrobial dosing
      Source IDH51-26C3A1B2CA66F946BAFA5048
      		https://idmp.ucsf.edu/pediatric-antimicrobial-dosing-benioff-childrens-hospitals (opens in a new tab)
      Source IDH51-6EE8CB70B4C108203A42A969
      		Professional institutional guidance
      Source IDH51-9687BA4AB3D59C3AB67494FC
      Source IDH51-2E56A5A9CA830B8CF451B393
      UCSF neonatal antimicrobial dosing
      Source IDH51-B610BA0FE8EA75CF08702366
      		https://idmp.ucsf.edu/neonatal-antimicrobial-dosing-benioff-childrens-hospitals (opens in a new tab)
      Source IDH51-CA1885CDA7DDADAEC9F5F315
      		Professional institutional guidance
      Source IDH51-3416C40C3D0042199E2D4465
      Other recovered source fields and original editorial metadata

      Original status words such as current, verified, or normalized describe the historical source release. They do not change the clinical review status of this release.

      Catalog source fields

      Id
      remdesivir
      Source IDH51-FEDD57701DE0DB5BA78484E1
      Generic name
      Remdesivir
      Source IDH51-D98F7D0D498EDA474C2C6B16
      Brand names
      1. Veklury
        Source IDH51-81D62AB20086D4B58D60BD15
      Class
      Antiviral
      Source IDH51-6D0D55B073994D624F305213
      Subclass
      Nucleotide analog
      Source IDH51-0544AE67E761F560B76EE43D
      Summary
      IV antiviral supplied as lyophilized powder or solution with formulation-specific preparation, required dilution, and 30- to 120-minute infusion.
      Source IDH51-C32F7BCF538EAF1296C1B936
      Populations
      1. Adult
        Source IDH51-0B7D763EEC59DD4C0B1CF1EE
      2. Pediatric including selected neonates per current label
        Source IDH51-FC5D2C81875E6D8901A785BC
      Evidence tier
      Core reference - verify current label
      Source IDH51-7713F463B617520F193B77AB
      High alert
      false
      Source IDH51-2E3FC77217F0E5C2F29B5C26
      Hazardous
      false
      Source IDH51-FC619E14B1FD897C48CF5011
      Status
      Active
      Source IDH51-0D12E8519F22C97B0CDA1094
      Reviewed
      2026-08-29
      Source IDH51-61DA13CDDFE38FC711D38938
      Version added
      1.2
      Source IDH51-B7488D16F5946E5A833A838E
      Sources
      LabelUrlKind
      Source IDH51-D6D85FDBCB28793387BB9DB7
      DailyMed label search
      Source IDH51-7E8806AB9C3FCD500931AC83
      		https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Remdesivir (opens in a new tab)
      Source IDH51-258CD6657CA0970A644F441B
      		Primary
      Source IDH51-32EF4CAF8E68FDFC8298E837
      Source IDH51-2E216322551081ED03738530
      GlobalRPh legacy IV dilution monograph
      Source IDH51-FACD320B5BC1ED9108BDA2BA
      		legacy:auto
      Source IDH51-B073AAF218C6ABB38680E81C
      		Legacy
      Source IDH51-63D1AF84783367AF2CA6F26A
      Clinical release verification
      Audit version
      3.4
      Source IDH51-7FD8C2158E11011DA42E0298
      Audited on
      2026-08-30
      Source IDH51-23C9BC5D023EC072E73ED4E0
      Level
      amber
      Source IDH51-A1B2E52DCA5C002E1D006059
      Release gate
      trusted_professional_source_present_exact_label_unconfirmed
      Source IDH51-4F823CD12CBD0337716C163F
      Exact current label candidate
      false
      Source IDH51-97EEB9C6ED42F424BB607413
      Numeric support ratio
      0
      Source IDH51-A25CE5C4F3DA9A3E74B49EAF
      Reference url count
      5
      Source IDH51-C19B9734BBCDA845402B9EBC
      Broken reference count
      0
      Source IDH51-8A71B67B31FED9BD20B1D068
      Point of use confirmation required
      true
      Source IDH51-0C2FDBBF2C7E18EDACE7C3E2
      Note
      Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
      Source IDH51-EAEA088125EC149AD9928B86
      Version updated
      5.1
      Source IDH51-3B1742B5749877DA7364A319

      Dosing source fields

      Id
      remdesivir
      Source IDH51-F1CE457560431EFA1568E30D
      Generic name
      Remdesivir
      Source IDH51-D822708A0E8B632CFE9D339E
      Coverage status
      direct_official_label_access_plus_local_snapshot
      Source IDH51-4F38136933170B1D472244BB
      Package insert
      Query name
      Remdesivir
      Source IDH51-C4CF5B18B45CAC5574AB0113
      Product and route must match
      true
      Source IDH51-BFB10C3F5ADCA6B46395A2A9
      Live current label enabled
      false
      Source IDH51-7C26BB831F0B0FAF716B13DA
      Source priority
      Reviewed local summary when available, then a verified DailyMed label or product search when available, followed by professional references and institutional policy.
      Source IDH51-3CAB551B844EEB54D070B135
      Direct official label access enabled
      true
      Source IDH51-78D81B2B700AE78A17C8E69D
      Outbound server request required
      false
      Source IDH51-3C890BE3D61158D94A9CBF00
      Local summary status
      not_bundled
      Source IDH51-0BCD9A5E75F247B6D1BFBD59
      Clinical review
      Locally normalized
      false
      Source IDH51-F5DC0984177A97565B3DDA2D
      Reviewed
      2026-08-29
      Source IDH51-DB4B81BDFD49BBC7BB4D17C9
      Status
      Direct official package-insert access enabled; indication-specific local normalization pending.
      Source IDH51-09E0E595AE15E7FD42F3A94B
      Clinical release verification
      Audit version
      3.4
      Source IDH51-F7E176C0487677213C47320F
      Audited on
      2026-08-30
      Source IDH51-9D0109C808F513727C35F0EA
      Level
      amber
      Source IDH51-E970CCEE97DB7A1BFC15417A
      Release gate
      trusted_professional_source_present_exact_label_unconfirmed
      Source IDH51-EE1DDAE4837B9F9A2DB3C83F
      Exact current label candidate
      false
      Source IDH51-BCD5EECC80C53CB9E46EB202
      Numeric support ratio
      0
      Source IDH51-0C280C2E11FAD0279492800D
      Reference url count
      5
      Source IDH51-A18FEB848591FA3922D00DD9
      Broken reference count
      0
      Source IDH51-45287AB7B2E4D653C81B5C72
      Point of use confirmation required
      true
      Source IDH51-2E675E592B5809347460337D
      Note
      Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
      Source IDH51-281B06F149636E1DEE12B401
      Historical preparation assessment

      Recovered v5.1 source content; historical, awaiting current review.

      Id
      remdesivir
      Source IDH51-15B265A1C07C7CA6E07810F8
      Name
      Remdesivir
      Source IDH51-69A7FCEE959C5CAC9D9F8524
      Brands
      Veklury
      Source IDH51-8162DBEFAC013E4D1BE6B155
      Therapeutic class
      Antiviral
      Source IDH51-F839BFC53568B845A9C87FA4
      Review version
      3.1
      Source IDH51-24A44A1F0E5B7B72AAE8FC18
      Review date
      2026-08-30
      Source IDH51-4D598E6097EB16D102143618
      Release status
      structured_record_current_label_not_confirmed
      Source IDH51-B103B24D522001E914F75F4B
      Market status
      Status
      no_current_us_iv_spl_confirmed
      Source IDH51-E3649D0F7192A1FF98C74C87
      Basis
      No high-confidence current IV SPL was automatically selected; legacy information is segregated
      Source IDH51-22286B816FFCCCF4E0CE0D78
      Ten point assessment
      Exact formulation
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-751E83199031CE90E487A67C
      Reconstitution concentration
      Reconstitute lyophilized vial with 19 mL Sterile Water for Injection; solution formulation does not require reconstitution. Use age/weight-appropriate formulation and label table.
      Source IDH51-8D7BEE2B1206A2C66BDC43A0
      Maximum or recommended final concentration
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-75B030CC17D4FDCA4EB0D664
      Appropriate standardized containers
      100 or 250 mL Weight-appropriate volume
      Source IDH51-5AF3B19049D3EFB9CD117F45
      Adult dosing range
      200 mg loading then 100 mg daily in common regimen Weight-based loading and maintenance when under 40 kg
      Source IDH51-6D48085C6E58F535CEA7ED3D
      Pediatric dosing range
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-01701AF649C86247A67BD790
      Neonatal dosing range
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-E1AD3CDEA4447F53312A6C20
      Infusion time
      Infuse over 30 to 120 minutes
      Source IDH51-9F2ABFE70C3666A712497F22
      Fluid restriction alternatives
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-7CD53230D4153133D3A3D172
      Current manufacturer labeling
      Match confidence
      unresolved
      Source IDH51-383659B5343A59D69287B4D8
      Field provenance
      Exact formulation
      Primary
      not_found
      Source IDH51-93DA555E0797D66947F0EA83
      Reconstitution concentration
      Primary
      existing_structured_record
      Source IDH51-DA440FF669206F1B2E1B6B9B
      Maximum or recommended final concentration
      Primary
      not_found
      Source IDH51-4B13953E25FC5B11395098C5
      Appropriate standardized containers
      Primary
      existing_structured_record
      Source IDH51-9D244E0A701D815F083370DD
      Adult dosing range
      Primary
      existing_structured_record
      Source IDH51-59697BF2BB39BE9574693050
      Pediatric dosing range
      Primary
      not_found
      Source IDH51-A2E57449A04EE9C008D9B15F
      Neonatal dosing range
      Primary
      not_found
      Source IDH51-D5BF148F45BF6C6EE7A99147
      Infusion time
      Primary
      existing_structured_record
      Source IDH51-51C65C0F461664AFED9687EB
      Fluid restriction alternatives
      Primary
      not_found
      Source IDH51-2FA6837359F6700FCB59BC84
      Current manufacturer labeling
      Primary
      DailyMed search gateway
      Source IDH51-280C13704D772E6D0DE43925
      Population applicability
      Adult
      Applicability
      supported_or_source_present
      Source IDH51-70E9E4FDE7D1EEE9DBC3CD44
      Guide generation allowed
      true
      Source IDH51-FA4F6B93A32B6112521B74C4
      Pediatric
      Applicability
      supported_or_source_present
      Source IDH51-B69A45A31FA70702891BA3D9
      Guide generation allowed
      false
      Source IDH51-8DAAB565E62F6C23507054E4
      Neonatal
      Applicability
      supported_or_source_present
      Source IDH51-7C8D8E77DDF40076515AFDEC
      Guide generation allowed
      false
      Source IDH51-FDABB94703AE18C0652A96DB
      Route presence
      Structured dilution
      true
      Source IDH51-7A5EB7556A72FA6BD510322F
      Iv push
      false
      Source IDH51-624A5734A610AC7437557E02
      Continuous infusion
      true
      Source IDH51-E046A17178A6676BA56EBE62
      Pediatric source
      true
      Source IDH51-32C8861925B3E2AC921E976E
      Neonatal source
      true
      Source IDH51-B3E85A84597AAA72A458AE38
      Legacy reference
      Status
      not_available
      Source IDH51-1DAE078571119420D051EA35
      Label resolution
      Status
      build_environment_network_unavailable
      Source IDH51-0DBCC2DA47E0329AB2C751AA
      Source files
      1. catalog.json
        Source IDH51-1F0E22C9F6BF48BF0320B5EB
      2. dosing.json
        Source IDH51-010DF41368BB076B75DFC07D
      3. new-in-v1.2.json
        Source IDH51-53352DAD445CC22D283ADE17
      Clinical release note
      Preparation instructions are released only at the evidence level shown. Legacy content remains visibly separate. Exact product, NDC, route, current labeling, and institutional policy must be confirmed.
      Source IDH51-2FAE7F3FA216BCE0A8F8B85A
      Historical statement IDs and source locations

      These IDs identify recovered source units. They are not evidence-qualified clinical claims.

      Historical IDOriginal source locationStatus
      H51-FEDD57701DE0DB5BA78484E1catalog.json
      /records/217/id      		Historical; current review incomplete
      H51-D98F7D0D498EDA474C2C6B16catalog.json
      /records/217/generic_name      		Historical; current review incomplete
      H51-81D62AB20086D4B58D60BD15catalog.json
      /records/217/brand_names/0      		Historical; current review incomplete
      H51-6D0D55B073994D624F305213catalog.json
      /records/217/class      		Historical; current review incomplete
      H51-0544AE67E761F560B76EE43Dcatalog.json
      /records/217/subclass      		Historical; current review incomplete
      H51-C32F7BCF538EAF1296C1B936catalog.json
      /records/217/summary      		Historical; current review incomplete
      H51-8DF646AEB7A4C13C9A44F0F6catalog.json
      /records/217/common_uses/0      		Historical; current review incomplete
      H51-006760AF95E341F49941C539catalog.json
      /records/217/preparations/0      		Historical; current review incomplete
      H51-FB6367DAEE2ED009DB90FC0Ecatalog.json
      /records/217/preparations/0/population      		Historical; current review incomplete
      H51-025FA0C6B08D9ACA8042626Bcatalog.json
      /records/217/preparations/0/amount      		Historical; current review incomplete
      H51-D896B4F4E5EC38AAE880ACF3catalog.json
      /records/217/preparations/0/reconstitution      		Historical; current review incomplete
      H51-7773C8BF47872E6A34028BF8catalog.json
      /records/217/preparations/0/diluent      		Historical; current review incomplete
      H51-00FD40E464F70435A06910B3catalog.json
      /records/217/preparations/0/final_volume      		Historical; current review incomplete
      H51-114BC91A2A561C46F8BA917Fcatalog.json
      /records/217/preparations/0/concentration      		Historical; current review incomplete
      H51-F11604BEC3340BD59E7AC9C7catalog.json
      /records/217/preparations/0/rate      		Historical; current review incomplete
      H51-F2B18F7D664FFC004841D1EEcatalog.json
      /records/217/preparations/0/stability      		Historical; current review incomplete
      H51-FD8A45F014052A716AEA83A9catalog.json
      /records/217/preparations/0/notes      		Historical; current review incomplete
      H51-D270098D0A77FEADA30522BFcatalog.json
      /records/217/preparations/1      		Historical; current review incomplete
      H51-07380EF15B22776892D52BC8catalog.json
      /records/217/preparations/1/population      		Historical; current review incomplete
      H51-26B1BB4FC1AE41F161CA3B4Dcatalog.json
      /records/217/preparations/1/amount      		Historical; current review incomplete
      H51-1504AB3BCB21A4F8E2D08CEAcatalog.json
      /records/217/preparations/1/reconstitution      		Historical; current review incomplete
      H51-CEF4A6CFBAD9E4FC64DC7B9Ccatalog.json
      /records/217/preparations/1/diluent      		Historical; current review incomplete
      H51-6F2385479E3162FCE9540F78catalog.json
      /records/217/preparations/1/final_volume      		Historical; current review incomplete
      H51-991E45C15691301CA73BBB0Acatalog.json
      /records/217/preparations/1/concentration      		Historical; current review incomplete
      H51-FF924E4B2446DC0218284CBDcatalog.json
      /records/217/preparations/1/rate      		Historical; current review incomplete
      H51-8EB5ABE7C6A1DBB4B1083FD6catalog.json
      /records/217/preparations/1/stability      		Historical; current review incomplete
      H51-C993F6E6944E7F62D6BD47FEcatalog.json
      /records/217/preparations/1/notes      		Historical; current review incomplete
      H51-18240A8704174CE20144D2D9catalog.json
      /records/217/warnings/0      		Historical; current review incomplete
      H51-21CB65A0AE81EDB37131ED4Acatalog.json
      /records/217/warnings/1      		Historical; current review incomplete
      H51-454F0F1DC77CFFE0D241D1E0catalog.json
      /records/217/monitoring/0      		Historical; current review incomplete
      H51-27C1365195BA1CE8888E644Acatalog.json
      /records/217/monitoring/1      		Historical; current review incomplete
      H51-78741D3BD79D117B69743EAFcatalog.json
      /records/217/monitoring/2      		Historical; current review incomplete
      H51-0B7D763EEC59DD4C0B1CF1EEcatalog.json
      /records/217/populations/0      		Historical; current review incomplete
      H51-FC5D2C81875E6D8901A785BCcatalog.json
      /records/217/populations/1      		Historical; current review incomplete
      H51-7713F463B617520F193B77ABcatalog.json
      /records/217/evidence_tier      		Historical; current review incomplete
      H51-2E3FC77217F0E5C2F29B5C26catalog.json
      /records/217/high_alert      		Historical; current review incomplete
      H51-FC619E14B1FD897C48CF5011catalog.json
      /records/217/hazardous      		Historical; current review incomplete
      H51-0D12E8519F22C97B0CDA1094catalog.json
      /records/217/status      		Historical; current review incomplete
      H51-61DA13CDDFE38FC711D38938catalog.json
      /records/217/reviewed      		Historical; current review incomplete
      H51-B7488D16F5946E5A833A838Ecatalog.json
      /records/217/version_added      		Historical; current review incomplete
      H51-D6D85FDBCB28793387BB9DB7catalog.json
      /records/217/sources/0      		Historical; current review incomplete
      H51-7E8806AB9C3FCD500931AC83catalog.json
      /records/217/sources/0/label      		Historical; current review incomplete
      H51-258CD6657CA0970A644F441Bcatalog.json
      /records/217/sources/0/url      		Historical; current review incomplete
      H51-32EF4CAF8E68FDFC8298E837catalog.json
      /records/217/sources/0/kind      		Historical; current review incomplete
      H51-2E216322551081ED03738530catalog.json
      /records/217/sources/1      		Historical; current review incomplete
      H51-FACD320B5BC1ED9108BDA2BAcatalog.json
      /records/217/sources/1/label      		Historical; current review incomplete
      H51-B073AAF218C6ABB38680E81Ccatalog.json
      /records/217/sources/1/url      		Historical; current review incomplete
      H51-63D1AF84783367AF2CA6F26Acatalog.json
      /records/217/sources/1/kind      		Historical; current review incomplete
      H51-4DE4E5FB2AF60D34AC4A7F39catalog.json
      /records/217/legacy_title      		Historical; current review incomplete
      H51-7FD8C2158E11011DA42E0298catalog.json
      /records/217/clinical_release_verification/audit_version      		Historical; current review incomplete
      H51-23C9BC5D023EC072E73ED4E0catalog.json
      /records/217/clinical_release_verification/audited_on      		Historical; current review incomplete
      H51-A1B2E52DCA5C002E1D006059catalog.json
      /records/217/clinical_release_verification/level      		Historical; current review incomplete
      H51-4F823CD12CBD0337716C163Fcatalog.json
      /records/217/clinical_release_verification/release_gate      		Historical; current review incomplete
      H51-97EEB9C6ED42F424BB607413catalog.json
      /records/217/clinical_release_verification/exact_current_label_candidate      		Historical; current review incomplete
      H51-4242B95C67559896B8A47FACcatalog.json
      /records/217/clinical_release_verification/selected_setid      		Historical; current review incomplete
      H51-034F1D2BAB0EB39A4B9C8223catalog.json
      /records/217/clinical_release_verification/selected_label_title      		Historical; current review incomplete
      H51-A25CE5C4F3DA9A3E74B49EAFcatalog.json
      /records/217/clinical_release_verification/numeric_support_ratio      		Historical; current review incomplete
      H51-C19B9734BBCDA845402B9EBCcatalog.json
      /records/217/clinical_release_verification/reference_url_count      		Historical; current review incomplete
      H51-8A71B67B31FED9BD20B1D068catalog.json
      /records/217/clinical_release_verification/broken_reference_count      		Historical; current review incomplete
      H51-0C2FDBBF2C7E18EDACE7C3E2catalog.json
      /records/217/clinical_release_verification/point_of_use_confirmation_required      		Historical; current review incomplete
      H51-EAEA088125EC149AD9928B86catalog.json
      /records/217/clinical_release_verification/note      		Historical; current review incomplete
      H51-7BEB00CD54E78D99EDF2DA3Dcatalog.json
      /records/217/clinical_release_verification/dailymed_search_url      		Historical; current review incomplete
      H51-3B1742B5749877DA7364A319catalog.json
      /records/217/version_updated      		Historical; current review incomplete
      H51-B63BCC538C7D742C6B35AF22dailymed-label-snapshots-v5.1.json
      /records/40/id      		Historical; current review incomplete
      H51-7F2F0EEE57FC0F25C89DB08Fdailymed-label-snapshots-v5.1.json
      /records/40/catalog_name      		Historical; current review incomplete
      H51-2B56366B509DFA926A8B0607dailymed-label-snapshots-v5.1.json
      /records/40/selection_status      		Historical; current review incomplete
      H51-83E5E086147C66E21F12CEECdailymed-label-snapshots-v5.1.json
      /records/40/confidence      		Historical; current review incomplete
      H51-B102E51F24D0DE9347356FDFdailymed-label-snapshots-v5.1.json
      /records/40/match_path      		Historical; current review incomplete
      H51-D0E8AC1FE8BA17B5DDE93889dailymed-label-snapshots-v5.1.json
      /records/40/brand_name      		Historical; current review incomplete
      H51-776B1F5D33EE4DFC238957B9dailymed-label-snapshots-v5.1.json
      /records/40/label_title      		Historical; current review incomplete
      H51-5FAE3D58CDE18F123BF3FF0Bdailymed-label-snapshots-v5.1.json
      /records/40/setid      		Historical; current review incomplete
      H51-1EE71CD83D4ECF79DEF15CFDdailymed-label-snapshots-v5.1.json
      /records/40/route      		Historical; current review incomplete
      H51-7602DE5580859B2A9039116Cdailymed-label-snapshots-v5.1.json
      /records/40/dosage_form      		Historical; current review incomplete
      H51-23E51DC2E659CD42E2467CFEdailymed-label-snapshots-v5.1.json
      /records/40/dosage_administration_summary/0      		Historical; current review incomplete
      H51-21A11E9A22FA55F90AEED13Cdailymed-label-snapshots-v5.1.json
      /records/40/dosage_administration_summary/1      		Historical; current review incomplete
      H51-1AA02A9FAA4BB28EAA03FD00dailymed-label-snapshots-v5.1.json
      /records/40/dosage_administration_summary/2      		Historical; current review incomplete
      H51-0FA5C1D1291400414F5264C8dailymed-label-snapshots-v5.1.json
      /records/40/dosage_forms_strengths/0      		Historical; current review incomplete
      H51-40BFE097EF260753D2C4FBCCdailymed-label-snapshots-v5.1.json
      /records/40/dosage_forms_strengths/1      		Historical; current review incomplete
      H51-FD0219CA05C347628B8A92F9dailymed-label-snapshots-v5.1.json
      /records/40/mechanism_summary      		Historical; current review incomplete
      H51-79F1AA3F7DDF42602EEDC3C3dailymed-label-snapshots-v5.1.json
      /records/40/scope_note      		Historical; current review incomplete
      H51-CF920816B18C42D069030556dailymed-label-snapshots-v5.1.json
      /records/40/labeler      		Historical; current review incomplete
      H51-479D8595C70CAF688009C1C2dailymed-label-snapshots-v5.1.json
      /records/40/official_label_url      		Historical; current review incomplete
      H51-C9F1CD31B23256380F793714dailymed-label-snapshots-v5.1.json
      /records/40/reviewed_on      		Historical; current review incomplete
      H51-DE2A32BF60E6BE90448EC945dailymed-label-snapshots-v5.1.json
      /records/40/mechanism_source      		Historical; current review incomplete
      H51-570673715AB10D8C140A037Adailymed-label-snapshots-v5.1.json
      /records/40/source_sections/0      		Historical; current review incomplete
      H51-BA1FBEF4366D62E84EF11B2Ddailymed-label-snapshots-v5.1.json
      /records/40/source_sections/1      		Historical; current review incomplete
      H51-E6A98A478E669C4778F725C4dailymed-label-snapshots-v5.1.json
      /records/40/source_sections/2      		Historical; current review incomplete
      H51-2F41D8A35B901B5D197CF1DCdailymed-label-snapshots-v5.1.json
      /records/40/retrieval_method      		Historical; current review incomplete
      H51-F5A9071EE22F7963F2B88194dailymed-label-snapshots-v5.1.json
      /records/40/label_status      		Historical; current review incomplete
      H51-981D824C1C023D758FA9E2BBdailymed-label-snapshots-v5.1.json
      /records/40/disclaimer      		Historical; current review incomplete
      H51-F1CE457560431EFA1568E30Ddosing.json
      /records/217/id      		Historical; current review incomplete
      H51-D822708A0E8B632CFE9D339Edosing.json
      /records/217/generic_name      		Historical; current review incomplete
      H51-4F38136933170B1D472244BBdosing.json
      /records/217/coverage_status      		Historical; current review incomplete
      H51-C4CF5B18B45CAC5574AB0113dosing.json
      /records/217/package_insert/query_name      		Historical; current review incomplete
      H51-99DEC02689D427C37480E142dosing.json
      /records/217/package_insert/preferred_setid      		Historical; current review incomplete
      H51-BFB10C3F5ADCA6B46395A2A9dosing.json
      /records/217/package_insert/product_and_route_must_match      		Historical; current review incomplete
      H51-7C26BB831F0B0FAF716B13DAdosing.json
      /records/217/package_insert/live_current_label_enabled      		Historical; current review incomplete
      H51-3CAB551B844EEB54D070B135dosing.json
      /records/217/package_insert/source_priority      		Historical; current review incomplete
      H51-78D81B2B700AE78A17C8E69Ddosing.json
      /records/217/package_insert/direct_official_label_access_enabled      		Historical; current review incomplete
      H51-3C890BE3D61158D94A9CBF00dosing.json
      /records/217/package_insert/outbound_server_request_required      		Historical; current review incomplete
      H51-0BCD9A5E75F247B6D1BFBD59dosing.json
      /records/217/package_insert/local_summary_status      		Historical; current review incomplete
      H51-3892ACECA10D0284AEB78FF3dosing.json
      /records/217/renal/classification      		Historical; current review incomplete
      H51-9E097E79A3DDD1729AC48341dosing.json
      /records/217/renal/summary      		Historical; current review incomplete
      H51-1E529D18C029935DADB40C02dosing.json
      /records/217/renal/method_note      		Historical; current review incomplete
      H51-36FD0D1E7BE590211BF7AC70dosing.json
      /records/217/existing_route_snapshots/0      		Historical; current review incomplete
      H51-3B7EC60C5C105A1AC52FF215dosing.json
      /records/217/existing_route_snapshots/0/route      		Historical; current review incomplete
      H51-DAEF11868CA9AE80D8CA37B2dosing.json
      /records/217/existing_route_snapshots/0/population      		Historical; current review incomplete
      H51-310B3E9AF8272BBF65F0FD31dosing.json
      /records/217/existing_route_snapshots/0/indication      		Historical; current review incomplete
      H51-5470E45B351D8495C595BF4Ddosing.json
      /records/217/existing_route_snapshots/0/dose      		Historical; current review incomplete
      H51-19A3CFE8A0E16C66E8B1D1B8dosing.json
      /records/217/existing_route_snapshots/0/interval      		Historical; current review incomplete
      H51-82F3787C9475044D088C63A2dosing.json
      /records/217/existing_route_snapshots/0/duration      		Historical; current review incomplete
      H51-C0BBD2BAC9D799061001A015dosing.json
      /records/217/existing_route_snapshots/0/administration      		Historical; current review incomplete
      H51-C751FE819F1C5FB32B5BF273dosing.json
      /records/217/existing_route_snapshots/0/source_level      		Historical; current review incomplete
      H51-EE050F98029868396D453E70dosing.json
      /records/217/existing_route_snapshots/0/notes      		Historical; current review incomplete
      H51-E832766D5797285A4C723388dosing.json
      /records/217/existing_route_snapshots/1      		Historical; current review incomplete
      H51-576A02604211DE59EC54AAD5dosing.json
      /records/217/existing_route_snapshots/1/route      		Historical; current review incomplete
      H51-0D764B38E5D1DA951EFD871Adosing.json
      /records/217/existing_route_snapshots/1/population      		Historical; current review incomplete
      H51-B600A570544AF1D3B2B462EBdosing.json
      /records/217/existing_route_snapshots/1/indication      		Historical; current review incomplete
      H51-BD0F6E0A0D57153517AB2BCDdosing.json
      /records/217/existing_route_snapshots/1/dose      		Historical; current review incomplete
      H51-1562D124974C8EA617D9E714dosing.json
      /records/217/existing_route_snapshots/1/interval      		Historical; current review incomplete
      H51-4826167DF91B0234B3DD4317dosing.json
      /records/217/existing_route_snapshots/1/duration      		Historical; current review incomplete
      H51-99720EB5F5F07A0BCF67392Ddosing.json
      /records/217/existing_route_snapshots/1/administration      		Historical; current review incomplete
      H51-8082DC1039031B5C64739C07dosing.json
      /records/217/existing_route_snapshots/1/source_level      		Historical; current review incomplete
      H51-FEE90E63AC97918005A8CF87dosing.json
      /records/217/existing_route_snapshots/1/notes      		Historical; current review incomplete
      H51-49BE17625649164F03E220FBdosing.json
      /records/217/professional_sources/0      		Historical; current review incomplete
      H51-85F68C86913E3F6CE8332A44dosing.json
      /records/217/professional_sources/0/label      		Historical; current review incomplete
      H51-7E5115C63CB69EC266818915dosing.json
      /records/217/professional_sources/0/url      		Historical; current review incomplete
      H51-4A91461B7EA1AD6C9E7D28C0dosing.json
      /records/217/professional_sources/0/kind      		Historical; current review incomplete
      H51-BDC779174F72CECB3FDE07DBdosing.json
      /records/217/professional_sources/1      		Historical; current review incomplete
      H51-F985C229517291699A01D3E7dosing.json
      /records/217/professional_sources/1/label      		Historical; current review incomplete
      H51-4EABAEF4FDC0BAB4358F192Fdosing.json
      /records/217/professional_sources/1/url      		Historical; current review incomplete
      H51-9FCA4EAD75AA4347C599EC60dosing.json
      /records/217/professional_sources/1/kind      		Historical; current review incomplete
      H51-AC92F6697ACA70461CA29756dosing.json
      /records/217/professional_sources/2      		Historical; current review incomplete
      H51-26C3A1B2CA66F946BAFA5048dosing.json
      /records/217/professional_sources/2/label      		Historical; current review incomplete
      H51-6EE8CB70B4C108203A42A969dosing.json
      /records/217/professional_sources/2/url      		Historical; current review incomplete
      H51-9687BA4AB3D59C3AB67494FCdosing.json
      /records/217/professional_sources/2/kind      		Historical; current review incomplete
      H51-2E56A5A9CA830B8CF451B393dosing.json
      /records/217/professional_sources/3      		Historical; current review incomplete
      H51-B610BA0FE8EA75CF08702366dosing.json
      /records/217/professional_sources/3/label      		Historical; current review incomplete
      H51-CA1885CDA7DDADAEC9F5F315dosing.json
      /records/217/professional_sources/3/url      		Historical; current review incomplete
      H51-3416C40C3D0042199E2D4465dosing.json
      /records/217/professional_sources/3/kind      		Historical; current review incomplete
      H51-F5DC0984177A97565B3DDA2Ddosing.json
      /records/217/clinical_review/locally_normalized      		Historical; current review incomplete
      H51-DB4B81BDFD49BBC7BB4D17C9dosing.json
      /records/217/clinical_review/reviewed      		Historical; current review incomplete
      H51-09E0E595AE15E7FD42F3A94Bdosing.json
      /records/217/clinical_review/status      		Historical; current review incomplete
      H51-F7E176C0487677213C47320Fdosing.json
      /records/217/clinical_release_verification/audit_version      		Historical; current review incomplete
      H51-9D0109C808F513727C35F0EAdosing.json
      /records/217/clinical_release_verification/audited_on      		Historical; current review incomplete
      H51-E970CCEE97DB7A1BFC15417Adosing.json
      /records/217/clinical_release_verification/level      		Historical; current review incomplete
      H51-EE1DDAE4837B9F9A2DB3C83Fdosing.json
      /records/217/clinical_release_verification/release_gate      		Historical; current review incomplete
      H51-BCD5EECC80C53CB9E46EB202dosing.json
      /records/217/clinical_release_verification/exact_current_label_candidate      		Historical; current review incomplete
      H51-B32F3CC5B5417EC0AFB1E13Cdosing.json
      /records/217/clinical_release_verification/selected_setid      		Historical; current review incomplete
      H51-40A823BD483CCF7FB965F4A3dosing.json
      /records/217/clinical_release_verification/selected_label_title      		Historical; current review incomplete
      H51-0C280C2E11FAD0279492800Ddosing.json
      /records/217/clinical_release_verification/numeric_support_ratio      		Historical; current review incomplete
      H51-A18FEB848591FA3922D00DD9dosing.json
      /records/217/clinical_release_verification/reference_url_count      		Historical; current review incomplete
      H51-45287AB7B2E4D653C81B5C72dosing.json
      /records/217/clinical_release_verification/broken_reference_count      		Historical; current review incomplete
      H51-2E675E592B5809347460337Ddosing.json
      /records/217/clinical_release_verification/point_of_use_confirmation_required      		Historical; current review incomplete
      H51-281B06F149636E1DEE12B401dosing.json
      /records/217/clinical_release_verification/note      		Historical; current review incomplete
      H51-B5DDB9C8AF355003B7B22E8Fdosing.json
      /records/217/clinical_release_verification/dailymed_search_url      		Historical; current review incomplete
      H51-3EE03E2FABDE8EAAC50447F4first-look-v5.1.json
      /records/217/id      		Historical; current review incomplete
      H51-3E312B5598C3385E142248F4first-look-v5.1.json
      /records/217/generic_name      		Historical; current review incomplete
      H51-BBD597507845519771CAC329first-look-v5.1.json
      /records/217/class      		Historical; current review incomplete
      H51-9C6AB8179EC96AD09121265Ffirst-look-v5.1.json
      /records/217/subclass      		Historical; current review incomplete
      H51-0EDFBE7EB482E6023783C673first-look-v5.1.json
      /records/217/primary_uses/0      		Historical; current review incomplete
      H51-F8F5F687D61EFF0AD2B3CFB4first-look-v5.1.json
      /records/217/mechanism      		Historical; current review incomplete
      H51-12C98E8B94DB1A226DE2A762first-look-v5.1.json
      /records/217/mechanism_level      		Historical; current review incomplete
      H51-830375731F7D6B4F5754AA84first-look-v5.1.json
      /records/217/basic_dosing_orientation      		Historical; current review incomplete
      H51-C7D4E675B99BDDD0B10E5DCBfirst-look-v5.1.json
      /records/217/administration_orientation      		Historical; current review incomplete
      H51-C939BB9FAEC15DFD8ABCDDC4first-look-v5.1.json
      /records/217/renal_and_population_orientation      		Historical; current review incomplete
      H51-438E846DC7F161946F6EFC40first-look-v5.1.json
      /records/217/key_safety_orientation/0      		Historical; current review incomplete
      H51-9365742A7BAC36D93B2CD4CFfirst-look-v5.1.json
      /records/217/key_safety_orientation/1      		Historical; current review incomplete
      H51-366C0898A21D25D91BE93E2Afirst-look-v5.1.json
      /records/217/coverage_path      		Historical; current review incomplete
      H51-F65606D938EA15AA40C456C4first-look-v5.1.json
      /records/217/coverage_path_label      		Historical; current review incomplete
      H51-83BC073A7A855ABD8A34DEE0first-look-v5.1.json
      /records/217/official_label_url      		Historical; current review incomplete
      H51-A8B19111AC024862F0664F49first-look-v5.1.json
      /records/217/legacy_title      		Historical; current review incomplete
      H51-B02E072D7EBB7C03B83087D6first-look-v5.1.json
      /records/217/review_note      		Historical; current review incomplete
      H51-5E6D7D91B264175F571D50C2first-look-v5.1.json
      /records/217/search_text      		Historical; current review incomplete
      H51-B36AA5A8E017310C17AB4295first-look-v5.1.json
      /records/217/official_search_url      		Historical; current review incomplete
      H51-95B25C3195C486DF44AE3F60first-look-v5.1.json
      /records/217/official_access_mode      		Historical; current review incomplete
      H51-A6C23E5830214125FA787356first-look-v5.1.json
      /records/217/official_access_url      		Historical; current review incomplete
      H51-1B030878C3AAF9E7640429B5first-look-v5.1.json
      /records/217/official_search_query      		Historical; current review incomplete
      H51-FC1D49AB09B91E59159293A8first-look-v5.1.json
      /records/217/official_access_reason      		Historical; current review incomplete
      H51-103B2104E953C771FEB2D3C4first-look-v5.1.json
      /records/217/label_snapshot_available      		Historical; current review incomplete
      H51-B847D79AF26FA203217D49D2first-look-v5.1.json
      /records/217/label_snapshot_setid      		Historical; current review incomplete
      H51-15B265A1C07C7CA6E07810F8preparation-assessments-v3.8.json
      /217/id      		Historical; current review incomplete
      H51-69A7FCEE959C5CAC9D9F8524preparation-assessments-v3.8.json
      /217/name      		Historical; current review incomplete
      H51-8162DBEFAC013E4D1BE6B155preparation-assessments-v3.8.json
      /217/brands      		Historical; current review incomplete
      H51-F839BFC53568B845A9C87FA4preparation-assessments-v3.8.json
      /217/therapeutic_class      		Historical; current review incomplete
      H51-24A44A1F0E5B7B72AAE8FC18preparation-assessments-v3.8.json
      /217/review_version      		Historical; current review incomplete
      H51-4D598E6097EB16D102143618preparation-assessments-v3.8.json
      /217/review_date      		Historical; current review incomplete
      H51-B103B24D522001E914F75F4Bpreparation-assessments-v3.8.json
      /217/release_status      		Historical; current review incomplete
      H51-E3649D0F7192A1FF98C74C87preparation-assessments-v3.8.json
      /217/market_status/status      		Historical; current review incomplete
      H51-22286B816FFCCCF4E0CE0D78preparation-assessments-v3.8.json
      /217/market_status/basis      		Historical; current review incomplete
      H51-751E83199031CE90E487A67Cpreparation-assessments-v3.8.json
      /217/ten_point_assessment/exact_formulation      		Historical; current review incomplete
      H51-8D7BEE2B1206A2C66BDC43A0preparation-assessments-v3.8.json
      /217/ten_point_assessment/reconstitution_concentration      		Historical; current review incomplete
      H51-75B030CC17D4FDCA4EB0D664preparation-assessments-v3.8.json
      /217/ten_point_assessment/maximum_or_recommended_final_concentration      		Historical; current review incomplete
      H51-5AF3B19049D3EFB9CD117F45preparation-assessments-v3.8.json
      /217/ten_point_assessment/appropriate_standardized_containers      		Historical; current review incomplete
      H51-6D48085C6E58F535CEA7ED3Dpreparation-assessments-v3.8.json
      /217/ten_point_assessment/adult_dosing_range      		Historical; current review incomplete
      H51-01701AF649C86247A67BD790preparation-assessments-v3.8.json
      /217/ten_point_assessment/pediatric_dosing_range      		Historical; current review incomplete
      H51-E1AD3CDEA4447F53312A6C20preparation-assessments-v3.8.json
      /217/ten_point_assessment/neonatal_dosing_range      		Historical; current review incomplete
      H51-9F2ABFE70C3666A712497F22preparation-assessments-v3.8.json
      /217/ten_point_assessment/infusion_time      		Historical; current review incomplete
      H51-7CD53230D4153133D3A3D172preparation-assessments-v3.8.json
      /217/ten_point_assessment/fluid_restriction_alternatives      		Historical; current review incomplete
      H51-731B81822EE60C1293700781preparation-assessments-v3.8.json
      /217/ten_point_assessment/current_manufacturer_labeling/setid      		Historical; current review incomplete
      H51-83BF88F8EFEA5F7E3A800383preparation-assessments-v3.8.json
      /217/ten_point_assessment/current_manufacturer_labeling/title      		Historical; current review incomplete
      H51-9FBFC9C28BD2847F35D6F832preparation-assessments-v3.8.json
      /217/ten_point_assessment/current_manufacturer_labeling/published_date      		Historical; current review incomplete
      H51-85F0E6E6FFF89A814180204Bpreparation-assessments-v3.8.json
      /217/ten_point_assessment/current_manufacturer_labeling/manufacturer      		Historical; current review incomplete
      H51-383659B5343A59D69287B4D8preparation-assessments-v3.8.json
      /217/ten_point_assessment/current_manufacturer_labeling/match_confidence      		Historical; current review incomplete
      H51-69DB397D5FDD848685F4D1A6preparation-assessments-v3.8.json
      /217/ten_point_assessment/current_manufacturer_labeling/url      		Historical; current review incomplete
      H51-93DA555E0797D66947F0EA83preparation-assessments-v3.8.json
      /217/field_provenance/exact_formulation/primary      		Historical; current review incomplete
      H51-DA440FF669206F1B2E1B6B9Bpreparation-assessments-v3.8.json
      /217/field_provenance/reconstitution_concentration/primary      		Historical; current review incomplete
      H51-4B13953E25FC5B11395098C5preparation-assessments-v3.8.json
      /217/field_provenance/maximum_or_recommended_final_concentration/primary      		Historical; current review incomplete
      H51-9D244E0A701D815F083370DDpreparation-assessments-v3.8.json
      /217/field_provenance/appropriate_standardized_containers/primary      		Historical; current review incomplete
      H51-59697BF2BB39BE9574693050preparation-assessments-v3.8.json
      /217/field_provenance/adult_dosing_range/primary      		Historical; current review incomplete
      H51-A2E57449A04EE9C008D9B15Fpreparation-assessments-v3.8.json
      /217/field_provenance/pediatric_dosing_range/primary      		Historical; current review incomplete
      H51-D5BF148F45BF6C6EE7A99147preparation-assessments-v3.8.json
      /217/field_provenance/neonatal_dosing_range/primary      		Historical; current review incomplete
      H51-51C65C0F461664AFED9687EBpreparation-assessments-v3.8.json
      /217/field_provenance/infusion_time/primary      		Historical; current review incomplete
      H51-2FA6837359F6700FCB59BC84preparation-assessments-v3.8.json
      /217/field_provenance/fluid_restriction_alternatives/primary      		Historical; current review incomplete
      H51-280C13704D772E6D0DE43925preparation-assessments-v3.8.json
      /217/field_provenance/current_manufacturer_labeling/primary      		Historical; current review incomplete
      H51-70E9E4FDE7D1EEE9DBC3CD44preparation-assessments-v3.8.json
      /217/population_applicability/adult/applicability      		Historical; current review incomplete
      H51-FA4F6B93A32B6112521B74C4preparation-assessments-v3.8.json
      /217/population_applicability/adult/guide_generation_allowed      		Historical; current review incomplete
      H51-B69A45A31FA70702891BA3D9preparation-assessments-v3.8.json
      /217/population_applicability/pediatric/applicability      		Historical; current review incomplete
      H51-8DAAB565E62F6C23507054E4preparation-assessments-v3.8.json
      /217/population_applicability/pediatric/guide_generation_allowed      		Historical; current review incomplete
      H51-7C8D8E77DDF40076515AFDECpreparation-assessments-v3.8.json
      /217/population_applicability/neonatal/applicability      		Historical; current review incomplete
      H51-FDABB94703AE18C0652A96DBpreparation-assessments-v3.8.json
      /217/population_applicability/neonatal/guide_generation_allowed      		Historical; current review incomplete
      H51-7A5EB7556A72FA6BD510322Fpreparation-assessments-v3.8.json
      /217/route_presence/structured_dilution      		Historical; current review incomplete
      H51-624A5734A610AC7437557E02preparation-assessments-v3.8.json
      /217/route_presence/iv_push      		Historical; current review incomplete
      H51-E046A17178A6676BA56EBE62preparation-assessments-v3.8.json
      /217/route_presence/continuous_infusion      		Historical; current review incomplete
      H51-32C8861925B3E2AC921E976Epreparation-assessments-v3.8.json
      /217/route_presence/pediatric_source      		Historical; current review incomplete
      H51-B3E85A84597AAA72A458AE38preparation-assessments-v3.8.json
      /217/route_presence/neonatal_source      		Historical; current review incomplete
      H51-1DAE078571119420D051EA35preparation-assessments-v3.8.json
      /217/legacy_reference/status      		Historical; current review incomplete
      H51-0DBCC2DA47E0329AB2C751AApreparation-assessments-v3.8.json
      /217/label_resolution/status      		Historical; current review incomplete
      H51-1F0E22C9F6BF48BF0320B5EBpreparation-assessments-v3.8.json
      /217/source_files/0      		Historical; current review incomplete
      H51-010DF41368BB076B75DFC07Dpreparation-assessments-v3.8.json
      /217/source_files/1      		Historical; current review incomplete
      H51-53352DAD445CC22D283ADE17preparation-assessments-v3.8.json
      /217/source_files/2      		Historical; current review incomplete
      H51-2FAE7F3FA216BCE0A8F8B85Apreparation-assessments-v3.8.json
      /217/clinical_release_note      		Historical; current review incomplete
      All medicationsReturn to medication headingApplication top